AMANDA JANULIS: Open Payments
NPI 1124743372 · GOODYEAR, AZ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$633 in 31 payments from 7 companies in 2025. Trend: 2023 $0 · 2024 $252 · 2025 $633
Food & beverage: $534Education: $99
| Company | Payments | Amount |
|---|---|---|
| GlaxoSmithKline, LLC. | 11 | $147 |
| AERIN MEDICAL INC. | 6 | $132 |
| GENZYME CORPORATION | 5 | $100 |
| SANOFI-AVENTIS U.S. LLC | 1 | $99 |
| Optinose US, Inc. | 4 | $82 |
| Novartis Pharmaceuticals Corporation | 3 | $50 |
| Regeneron Healthcare Solutions, Inc. | 1 | $22 |
Products named: DUPIXENT, NUCALA, VIVAER STYLUS, Xhance, Rhapsido.
Industry payments across AZ — which companies pay providers there.
